James P. Morken is the Jim and Louise Vanderslice Professor of Chemistry at Boston College. He obtained his B.S. in chemistry in 1989 from UC Santa Barbara working with Professor Bruce Rickborn, and a Ph.D. from Boston College in 1995 with Professor Amir Hoveyda. During his Ph.D. studies he performed research on the zirconium-catalyzed ethyl magnesation reaction. He was an NSF Postdoctoral Fellow with Stuart Schreiber at Harvard University where he undertook the diversity-based discovery of ligands for SH3 protein domains. In 1997, became an Assistant Professor at the University of North Carolina at Chapel Hill. He was promoted to Associate Professor in 2002 and in 2006 joined the faculty of Boston College. Professor Morken’s research focuses on the development of transition-metal-catalyzed asymmetric processes and their use in the efficient construction of complex natural products. The Morken group’s research has been recognized by awards from the David and Lucile Packard Foundation, the Alfred P. Sloan Foundation, a National Science CAREER Award, as well as awards from Astra-Zeneca, Bristol-Myers Squibb, Dow, DuPont, and GlaxoSmithKline.